CA2094913A1 - Transdermal nicotine absorption dosage unit and process - Google Patents

Transdermal nicotine absorption dosage unit and process

Info

Publication number
CA2094913A1
CA2094913A1 CA002094913A CA2094913A CA2094913A1 CA 2094913 A1 CA2094913 A1 CA 2094913A1 CA 002094913 A CA002094913 A CA 002094913A CA 2094913 A CA2094913 A CA 2094913A CA 2094913 A1 CA2094913 A1 CA 2094913A1
Authority
CA
Canada
Prior art keywords
nicotine
dosage unit
layer
transdermal
adhesive layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002094913A
Other languages
English (en)
French (fr)
Inventor
Chin-Chih Chiang
Jhili Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TBS Laboratories Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2094913A1 publication Critical patent/CA2094913A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
CA002094913A 1991-06-26 1992-06-24 Transdermal nicotine absorption dosage unit and process Abandoned CA2094913A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72112991A 1991-06-26 1991-06-26
US721,129 1991-06-26

Publications (1)

Publication Number Publication Date
CA2094913A1 true CA2094913A1 (en) 1992-12-27

Family

ID=24896654

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002094913A Abandoned CA2094913A1 (en) 1991-06-26 1992-06-24 Transdermal nicotine absorption dosage unit and process

Country Status (6)

Country Link
EP (1) EP0544900A4 (ja)
CN (1) CN1067811A (ja)
AU (1) AU2294192A (ja)
CA (1) CA2094913A1 (ja)
TW (1) TW221970B (ja)
WO (1) WO1993000057A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7323794A (en) * 1993-07-09 1995-02-06 Cygnus Therapeutic Systems Method and device for providing nicotine replacement therapy transdermally/transbuccally
JP5000932B2 (ja) * 2005-06-21 2012-08-15 日東電工株式会社 ニコチン含有経皮吸収製剤
ES2499067T3 (es) * 2005-10-13 2014-09-26 Nitto Denko Corporation Preparación transdérmica de nicotina y método de producción de la misma
EP2377540A1 (en) * 2010-03-31 2011-10-19 Hexal AG Transdermal patch containing 17-deacetyl norgestimate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
CH672888A5 (ja) * 1986-11-07 1990-01-15 Mepha Ag
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen

Also Published As

Publication number Publication date
WO1993000057A1 (en) 1993-01-07
CN1067811A (zh) 1993-01-13
TW221970B (ja) 1994-04-01
EP0544900A1 (en) 1993-06-09
EP0544900A4 (en) 1993-12-01
AU2294192A (en) 1993-01-25

Similar Documents

Publication Publication Date Title
US5145682A (en) Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
US5560922A (en) Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
EP0743842B1 (en) Drug-containing adhesive composite transdermal delivery device
EP1490052B1 (de) Vorrichtung zur transdermalen verabreichung von rotigotin-base
EP1585470B1 (en) Transdermal delivery of fentanyl
EP0614356B1 (en) Transdermal estradiol delivery system
CA2550704C (en) Nicotine transdermal delivery system
EP0371496A1 (en) Compositions for transdermal delivery of estradiol
KR100381997B1 (ko) 레보노르게스트렐의 투여를 위한 경피적 치료학적 시스템
PL175083B1 (pl) Przezskórny układ terapeutyczny do podawania galantaminy na skórę
US20060088580A1 (en) Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion
CA2387143C (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
WO1994006436A1 (de) Dexpanthenol-haltiges pflaster zur transdermalen applikation von steroidhormonen
WO2000048579A1 (de) Desoxypeganin-tts
CA2563496C (en) Nicotine transdermal preparation and production method thereof
CA2094913A1 (en) Transdermal nicotine absorption dosage unit and process
JPH07145061A (ja) 経皮吸収製剤
US20030175330A1 (en) Transdermal therapeutical system with a reduced tendency of the active substance to crystallize
PL172999B1 (pl) Terapeutyczny system przezskórny (TTS) do podawania fizostygminy na skórę i sposób wytwarzania terapeutycznego systemu przezskórnego do podawania fizostygminy na skórę
WO1993019708A1 (en) Transdermal albuterol absorption dosage unit and process

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 19990625